Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson’s disease: An open-label study
- 1 April 2017
- journal article
- research article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 37, 79-86
Abstract
No abstract availableKeywords
Funding Information
- OTKA (PD103964)
- Hungarian Brain Research Program (KTIA_13_NAP-A-II/10)
- New National Excellence Program of the Ministry of Human Capacities (ÚNKP-16-4-III)
- János Bolyai Scholarship of the Hungarian Academy of Sciences
This publication has 22 references indexed in Scilit:
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy studyThe Lancet Neurology, 2014
- Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7‐year experienceEuropean Journal of Neurology, 2013
- Which dyskinesia scale best detects treatment response?Movement Disorders, 2013
- Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson diseaseActa Neurologica Scandinavica, 2013
- Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's diseaseMovement Disorders, 2011
- Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: Impact on control of fluctuations and quality of lifeParkinsonism & Related Disorders, 2010
- The Unified Dyskinesia Rating Scale: Presentation and clinimetric profileMovement Disorders, 2008
- Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing resultsMovement Disorders, 2008
- The clinical relevance of changes in the Montgomery–Asberg Depression Rating Scale using the minimum clinically important difference approachCurrent Medical Research and Opinion, 2008
- No Adjustments Are Needed for Multiple ComparisonsEpidemiology, 1990